Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Chemoprotective drugs, such as amifostine, may protect normal cells
from the bad side effects of chemotherapy.
PURPOSE: Randomized phase I trial to study the effectiveness of amifostine in treating
patients who are receiving chemotherapy for recurrent or refractory solid tumors.
Phase:
Phase 1
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health